The lncRNA PAXIP1-AS1/ETS1/KIF14 axis could be considered as a target for glioma therapy, because of its contribution to invasion, migration, and angiogenesis in glioma tumors (Xu H. et al., 2019). The gene discussed is KIF14; the disease is central nervous system cancer.